[1] Rapid diagnosis of pneumococcal meningitis: implications for treatment and measuring disease burden

[2] Management of nonsevere pneumonia in military trainees with the urinary antigen test for Streptococcus pneumoniae: an innovative approach to targeted therapy

[3] Immunoglobulins and antibody response in children with protein-calorie malnutrition

[4] Rapid bacterial antigen detection is not clinically useful

[5] Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome

[6] Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia

[7] Comparison of Premier™ Rotaclone®, ProSpecT™, and RIDASCREEN® rotavirus enzyme immunoassay kits for detection of rotavirus antigen in stool specimens

[8] Use of the NOW Streptococcus pneumoniae urinary antigen test in cerebrospinal fluid for rapid diagnosis of pneumococcal meningitis

[9] Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses

[10] Immunological responses to monoassociated Bifidobacterium longum and their relation to prevention of bacterial invasion

[11] Persistent measles infection in malnourished children

[12] Respiratory syncytial virus infection of human mononuclear leukocytes in vitro and in vivo

[13] Antigen detection for the diagnosis of pneumonia

[14] Performance of the Binax NOW Streptococcus pneumoniae urinary antigen assay for diagnosis of pneumonia in children with underlying pulmonary diseases in the absence of acute pneumococcal infection

[15] Aerosolized immunoglobulin treatment of respiratory syncytial virus infection in infants

[16] Immunological effects of HIV-1 infection on the humoral response to malaria in an African population

[17] Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation

[18] Assessment of a rapid urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal infection in children

[19] Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infection

[20] Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization

[21] The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins

[22] Respiratory syncytial virus infection in human immunodeficiency virus-infected children

[23] Selected P. falciparum specific immune responses are maintained in AIDS adults in Burkina Faso

[24] Differential diagnosis of acute meningitis. An analysis of the predictive value of initial observations

[25] Yersinia pestis--etiologic agent of plague

[26] The 1A protein of respiratory syncytial virus is an integral membrane protein present as multiple, structurally distinct species

[27] Helminth- and Bacillus Calmette-Guérin-induced immunity in children sensitized in utero to filariasis and schistosomiasis

[28] Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies

[29] Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection

[30] The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection

[31] Early detection of streptococcal group antigens in skin samples by latex particle agglutination

[32] Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus

[33] The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection

[34] Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia

[35] Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice

[36] The two open reading frames of the 22K mRNA of human respiratory syncytial virus: sequence comparison of antigenic subgroups A and B and expression in vitro

[37] Cytotoxic lymphocytes in the lungs of mice infected with respiratory syncytial virus

[38] Esculetin from Fraxinus rhynchophylla attenuates atopic skin inflammation by inhibiting the expression of inflammatory cytokines

[39] Evaluation of a PCR assay for detection of Streptococcus pneumoniae in respiratory and nonrespiratory samples from adults with community-acquired pneumonia

[40] Cytotoxic T cell activity against the 22-kDa protein of human respiratory syncytial virus (RSV) is associated with a significant reduction in pulmonary RSV replication

[41] Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain

[42] Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse

[43] Oligomerization and post-translational processing of glycoprotein G of human respiratory syncytial virus: altered O-glycosylation in the presence of brefeldin A

[44] Murine cytotoxic T cells specific to respiratory syncytial virus recognize different antigenic subtypes of the virus

[45] Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen

[46] Experimental respiratory syncytial virus pneumonia in cebus monkeys

[47] Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults

[48] Antigenicity testing of plain and aluminium hydroxide-adsorbed whole-cell cholera vaccines

[49] Assessment of analysis of urinary pneumococcal antigen by immunochromatography for etiologic diagnosis of community-acquired pneumonia in adults

[50] Contribution of a pleural antigen assay (Binax NOW) to the diagnosis of pneumococcal pneumonia

[51] Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum

[52] Detection of Streptococcus pneumoniae antigen in bronchoalveolar lavage fluid samples by a rapid immunochromatographic membrane assay

[53] Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity

[54] Capsular polysaccharides of nongroupable streptococci that cross-react with pneumococcal group 19

[55] Characterization of oligosaccharide structures on a chimeric respiratory syncytial virus protein expressed in insect cell line Sf9

[56] A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia

[57] Effect of malnutrition in Ecuadorian children on titers of serum antibodies to various microbial antigens

[58] Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins

[59] Usefulness of the Streptococcus pneumoniae urinary antigen test in the treatment of community-acquired pneumonia

[60] Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract infections in adults

[61] Evaluation of Binax NOW, an assay for the detection of pneumococcal antigen in urine samples, performed among pediatric patients

[62] Latex agglutination test for diagnosing pneumococcal pneumonia in children in developing countries

[63] The NOW S. pneumoniae urinary antigen test positivity rate 6 weeks after pneumonia onset and among patients with COPD

[64] Inhibition of respiratory syncytial virus replication by antisense oligodeoxyribonucleotides

[65] Assessment of the Binax NOW Streptococcus pneumoniae urinary antigen test in children with nasopharyngeal pneumococcal carriage

[66] Streptococcus pneumoniae antigen test using positive blood culture bottles as an alternative method to diagnose pneumococcal bacteremia

[67] Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children

[68] Lymphocyte phenotyping in infants: maturation of lymphocyte subpopulations and the effects of HIV infection

[69] Results of the flow cytometry ACTG quality control program: analysis and findings

[70] Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study

[71] CD38 expression on CD8(+) T cells as a prognostic marker in vertically HIV-infected pediatric patients

[72] Immunophenotypic analysis of HIV-infected children: alterations within the first year of life, changes with disease progression, and longitudinal analyses of lymphocyte subsets

[73] Monitoring of cytomegalovirus infections by the CD8+CD38+ T-cell subset in kidney transplant recipients

[74] Immunophenotyping of T lymphocytes by three-color flow cytometry in healthy newborns, children, and adults

[75] Regulatory Roles of MicroRNAs in Diabetes

[76] Current situation and future prospects of Echinococcus granulosus vaccine candidates: A systematic review

[77] Topical Wound Healing Activity of Myricetin Isolated from Tecomaria capensis v. aurea

[78] The diagnosis of typhoid fever in the Democratic Republic of the Congo

[79] Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies

[80] Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani

[81] A human prostatic epithelial model of hormonal carcinogenesis

[82] Ultrastructural localization of epitopes recognized by monoclonal antibodies produced to rat Pneumocystis carinii

[83] The contribution of low affinity NGF receptor (p75NGFR) to delayed neuronal death after ischemia in the gerbil hippocampus

[84] Studies on leukocyte cultures in measles. II. Detection of measles virus antigen in human leucocytes by immunofluorescence

[85] [Investigation on the expression of microvessel pericyte coverage index and lymph vessel density in nasal polyps]

[86] Group A streptococcal Vir types are M-protein gene (emm) sequence type specific

[87] MUC18, a melanoma-progression associated molecule, and its potential role in tumor vascularization and hematogenous spread

[88] Reduction of morbidity and mortality rates for neonatal group B streptococcal disease through early diagnosis and chemoprophylaxis

[89] Antibacterial antibodies in rectal and colonic mucosa in ulcerative colitis

[90] emm Types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: What has changed in 11 years?

[91] The role of viruses in the aetiology of community-acquired pneumonia in adults

[92] Acquisition of HLA-DR and costimulatory molecules by T cells from allogeneic antigen presenting cells

[93] The rise and fall of Escherichia coli O15 in a London teaching hospital

[94] Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens

[95] Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition

[96] Enzyme immunoassays for viral diseases

[97] Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response

[98] Molecular epidemiology of impetiginous group A streptococcal infections in aboriginal communities of northern Australia

[99] Effects of measles on the immune response of Nigerian children

[100] Epidemiological analysis of non-M-typeable group A Streptococcus isolates from a Thai population in northern Thailand

[101] Ultrasensitive radioimmunoassay of prostate-specific antigen